Skip to Main Content

Paper Details

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Nat Med
317
2022
Author NameAffiliation
Christiane E AngermannUniversity and University Hospital of Wurzburg
John R TeerlinkSan Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco
Sean P CollinsVanderbilt University Medical Center and Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center
Mikhail KosiborodSaint Luke's Mid America Heart Institute
Mikhail KosiborodUniversity of Missouri-Kansas City
Mikhail KosiborodGeorge Institute for Global Health
Mikhail KosiborodUniversity of New South Wales
  • 1 - 7

Datasets

Release 1.2